Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Next Science - Appendix 4C - 31 December 2021 (ASX:NXS)

To view the Quarterly cash flow report for entities subject to Listing Rule 4.7B, download the attached PDF.

Next Science - Enhanced sales & distribution relationship with Zimmer (ASX:NXS)

Sydney, Australia Monday, 31 January 2022, Next Science Limited (ASX:NXS) (Next Science / Company) is pleased to announce that it has signed a US distribution agreement with Zimmer, Inc (a wholly ow...read more

Next Sciences XPERIENCETM cleared by TGA for sale in Australia (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) is delighted to announce that its proprietary XPERIENCETM Surgical Solution has been cleared by Australia’s Therapeutic Goods Administration (TGA)...read more

Next Science - Q3 FY21 Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Agreement signed with TELA Bio Inc (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) is pleased to announce that it has signed a multi-year distribution agreement with NASDAQ listed medical technology company, TELA Bio, Inc in relation t...read more

Next Science - Quarterly Activity Report & Appendix 4C - 30 September 2021 (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) today announces its Quarterly Activity Report and Appendix 4C Quarterly Cash Flow Report for the period 1 July 2021 to 30 September 2021 (Q3). In accord...read more

Next Science - Update on Irrimax complaint (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) advises that further to Next Science’s announcement on 27 August 2021, Irrimax Corporation has now served on Next Science its complaint in the Uni...read more

Next Science - Managing Director's Address - Half Year Results (ASX:NXS)

As you know, Next Science is a company whose purpose is to improve people’s health by eliminating or preventing infections. Through our unique technologies we have helped tens of thousands of ...read more

Next Science - Half Year Results Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Half Year Results (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) today announces its Half Year Report for the six months ended 30 June 2021. Highlights: - 1H Revenue US$3.9M (271% growth on prior half year) - G...read more

Next Science - Half Year Report & Appendix 4D (ASX:NXS)

To view the report and appendix, download the attached PDF.

Next Science - Irrimax complaint (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science / Company) advises that Irrimax Corporation has filed a complaint in the United States District Court for the Northern District of Georgia alleging commo...read more

Next Science - Record revenue growth in 1H 2021 (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) today announces its Quarterly Activity Report and Appendix 4C Quarterly Cash Flow Report for the period 1 April 2021 to 30 June 2021 (Q2). Highlights...read more

Next Science - Quarterly Activity Report - 30 June 2021 (ASX:NXS)

Judith Mitchell, Managing Director said: “In the first half of 2021, we delivered our best single half result since IPO. We reported 271% revenue growth (unaudited) on pcp (which was heavily p...read more

Next Science - Appendix 4C - 30 June 2021 (ASX:NXS)

To view the Quarterly cash flow report for entities subject to Listing Rule 4.7B, download the attached PDF.

Viewing: 61 - 75 of 200 Previous | Next